INOZYME PHARMA, INC. Operating Lease Liability
INOZYME PHARMA, INC. had Operating Lease Liability of $669.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2025-05-14
- 2025-03-31: Operating Lease, Liability $669.00K.
- 2024-12-31: Operating Lease, Liability $913.00K.
- 2024-09-30: Operating Lease, Liability $1.15M.
- 2024-06-30: Operating Lease, Liability $1.38M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-03-31 | $669.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $913.00K 10-K · filed 2025-03-10 |
| 2024-09-30 | $1.15M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $1.38M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $300.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $700.00K 10-K · filed 2024-03-12 |
| 2023-09-30 | $700.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $500.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $300.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $900.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $600.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $500.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-10 |
| 2021-06-30 | $3.70M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.90M 10-Q · filed 2021-05-12 |